EUVIMEDEUVIMED entdecken
Fall-Kontroll-Studie

Relation of Endocan Serum Levels with Patient Characteristics and Morphological Features of Uterine Fibroids: A Case-Control Study

Inci Başkır, Şebnem Özyer

Gynecologic and Obstetric Investigation · 2024

DOI: 10.1159/000542405 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Gynecologic and Obstetric Investigation, 2024. Verfasst von Inci Başkır und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology and Obstetrics Departments, Ankara City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Leiomyoma, Proteoglycans, Neoplasm Proteins, Uterine Neoplasms. Die Arbeit nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to compare the serum endocan levels of patients with uterine fibroids and the healthy control group.

Design

A case-control study was designed. Participants/Materials: The study group includes women diagnosed with uterine fibroids, and the control group includes healthy women.

Setting

The study was conducted at a tertiary education and research hospital with 130 women (uterine fibroid group, n = 65; control group, n = 65).

Methods

Serum endocan levels were determined in the study and control groups using the ELISA method. The number of uterine fibroids was identified, and the volume of uterine fibroids was calculated with ellipsoid formula by ultrasonography. The primary outcome parameter was serum endocan levels in patients with uterine fibroids and healthy control groups. Second, it is aimed to determine the distribution of the serum endocan level of patients according to uterine fibroid number, volume, and clinical presentation.

Results

The mean serum endocan level of patient with uterine fibroid was 145.18 ± 169.86 (median: 94.10; Q25–Q75%: 54.50–116.50) pg/mL; it was 88.94 ± 54.21 (median: 76.9; Q25–Q75%: 64.20–152.65) pg/mL in the control group (p = 0.016). According to ROC analysis, cutoff value of the endocan level for uterine fibroid was determined as ≥133.1 pg/mL. For the cutoff value of 133.1 pg/mL, sensitivity was 36.92%, specificity was 89.23%, positive predictive value was 77.40%, and negative predictive value was 58.60%. Above this cutoff value, a 4.8-fold increased significant risk (OR) for uterine fibroid was detected.

Limitations

The major limitation of the study is the lack of histopathological examination.

Conclusion

Serum endocan levels were found to be higher in women with uterine fibroids compared to the control group, so endocan may be considered as a significant serum marker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeiomyomaProteoglycansNeoplasm ProteinsUterine NeoplasmsHumansFemaleCase-Control StudiesAdultMiddle AgedBiomarkers, TumorUltrasonography

Stichwörter der Autor:innen

AngiogenesisESM-1EndocanFibroid volumeUterine fibroid

Substanzen

ESM1 protein, humanProteoglycansNeoplasm ProteinsBiomarkers, Tumor

Autor:innen und Institutionen

  • Gynecology and Obstetrics Departments, Ankara City Hospital, Ankara, Turkey.

Zitieren

APA

Başkır, I., & Özyer, Ş. (2024). Relation of Endocan Serum Levels with Patient Characteristics and Morphological Features of Uterine Fibroids: A Case-Control Study. Gynecologic and Obstetric Investigation. https://doi.org/10.1159/000542405

Vancouver

Başkır I, Özyer Ş. Relation of Endocan Serum Levels with Patient Characteristics and Morphological Features of Uterine Fibroids: A Case-Control Study. Gynecologic and Obstetric Investigation. 2024. doi:10.1159/000542405

BibTeX
@article{Bakr2024,
  author = {Başkır, Inci and Özyer, Şebnem},
  title = {Relation of Endocan Serum Levels with Patient Characteristics and Morphological Features of Uterine Fibroids: A Case-Control Study},
  journal = {Gynecologic and Obstetric Investigation},
  year = {2024},
  doi = {10.1159/000542405}
}
Kostenlos starten →